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Abstract: Melanin-concentrating hormone (MCH) is a 
cyclic 19 amino acid orexigenic hypothalamic peptide. 
MCH is located in the lateral and dorsal hypothalamus, 
as well as in the zona incerta. In mammals MCH increases 
food intake, contributes to regulation of energy balance, 
temperature, reproductive function, endocrine home-
ostasis and biological rhythms. Several studies have 
proved the significance of MCH in obesity, diabetes and 
depression.
Although the peptide is well-characterized in mouse 
models, much less is known about its functions in avians. 
In birds the MCH system especially in the lateral and basal 
hypothalamus has important connections to the limbic 
system and it coordinates the vegetative and endocrine 
functions, as well as the emotional behaviour. Pharma-
cological modulation of MCH system could contribute to 
the therapy of eating disorders and improve agricultural 
efficiency regarding avians. Reviewing the current know-
ledge on MCH system in human, rodents and avians may 
stimulate a new wave of studies in the field. 
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Abbreviations 
AGRP Agouti-related peptide
cAMP Cyclic adenosine monophosphate
cMCH Chicken melanin-concentrating hormone
CNS Central nervous system
DMH Dorsomedial hypothalamic nucleus
DRY Aspartic acid–arginine–tyrosine
GABA Gamma-aminobutyric acid 
GAD Glutamic acid decarboxylase
IL-6Rα Interleukin 6 receptor α
LHA Lateral hypothalamic area
MCH Melanin-concentrating hormone
MCHR Melanin-concentrating hormone receptor
NPY Neuropeptide Y
PKC Protein kinase C
PLC Phospholipase C
VGAT Vesicular GABA transporter
VGCC Voltage-gated Ca2+ channels
VGLUT Vesicular glutamate transporter
VMH Ventromedial nucleus of hypothalamus
1  Introduction
Food intake and energy homeostasis regulation is a 
complex process. Humoral and neuronal inputs from 
peripheral organs (i.e. gastrointestinal tract, adipose 
tissue) are integrated in well-defined brain regions. Hypo-
thalamus and brainstem centres work up these informa-
tion and decide on the enhancement or reduction of food 
intake. However, reflecting the complexity of regulation, 
higher order neocortical, subcortical and limbic areas  are 
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also involved (Figure 1.) [1]. To understand the precise 
mechanism of food intake regulation researchers estab-
lished several animal models. Although, majority of these 
studies were carried out in mice, comprehensive analysis 
on avians are inevitable for phylogenetical and economic 
reasons.
2  The melanin-concentrating 
hormone (MCH) system in human 
and rodents 
Pre-melanin-concentrating hormone (PMCH) gene 
encodes a preprotein. Proteolytical process generates dif-
ferent proteins (i.e. MCH, neuropeptide-glutamic acid-iso-
leucine, or neuropeptide-glycine-glutamic acid). In 
mammals MCH is a 19 amino acid peptide, the N-terminus 
is extended by two additional amino acids, with a highly 
conserved loop structure. In the central nervous system 
(CNS), in rodents and human the PMCH mRNA sequences 
have a high degree of homology with 90% overall nucleo-
tide identity (Figure 2).
MCH is limited to the magnocellular neurons in the 
lateral hypothalamus and the zona incerta (Figure 3.). 
These neurons have monosynaptic connections through-
out the brain, projecting to the cortex, amygdala, nucleus 
accumbens, olfactory tubercle and brainstem nuclei [2, 3]. 
Overexpression of MCH may enhance food intake, contrib-
utes to reduced glucose tolerance and provokes insulin 
resistance. In the last decade several research groups 
investigated the potential effects of MCH receptor (MCHR) 
antagonists on food intake regulation [4]. According to 
the results MCHR antagonists may be beneficial against 
obesity, anxiety and depression [3, 5]. A novel promising 
MCHR1 antagonist SNAP-7941 caused less food intake and 
body weight [6].
MCH has two G-coupled receptors, MCHR1 and MCHR2. 
MCHR1 is 353 amino acids long, has seven transmembrane 
domains, an aspartic acid–arginine–tyrosine (DRY) motif 
at the end of the third intracellular loop and three potential 
glycosylation sites at the N-terminus (Figure 4.). MCHR1 
gene is localized on chromosome 22q13.3. The receptor 
is highly conserved among mammals, sequence homol-
ogy between human and mouse is 95%; while between 
human and rat is 96%. When MCH binds to the receptor it 
suppresses the forskolin-stimulated cAMP activation and 
increases intracellular Ca2+ level [2, 7].
MCHR1 can couple to Gi, G0 and Gq proteins, however 
the interaction is stronger with Gi and Gq. It stimulates 
protein kinase C (PKC), phospholipase C (PLC) and other 
extracellular-signal-regulated kinase pathways (Figure 
5.). In the CNS it has diverse effects. Gi-coupled receptors 
are known to inhibit voltage-gated Ca2+ channels (VGCCs) 
and to activate K+-inward rectifying channels. MCH inhibit 
Ca2+ currents through the N-, P-, and with lesser degree 
Figure 1: Brain regions involved in food intake regulation (Human 
hemisphere, midsagittal view). 
Figure 2:  Phylogenetic tree based on the amino acids sequence 
of melanin-concentrating hormone (MCH). [Length of lines shows 
the degree of difference in 6 species compared to the sequence of 
mouse MCH].
Figure 3: Melanin-concentrating hormone immunopositive (brown) 
cells on formalin fixed paraffin embedded rat brain slides, haema-
toxylin counterstain. At low magnification (Panel A – 40x) there 
are strong immunoreactions in the hypothalamic area (circle). At 
higher magnification (Panel B - 400x) the reaction is limited to the 
cytoplasm (arrow).
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the L-types of VGCCs in the neurons of lateral hypothal-
amus [2].
MCHR1 is highly expressed in the cerebral cortex, 
basal ganglia, hypothalamus, and brainstem. Interest-
ingly, the highest expression is observed in extrahypo-
thalamic areas anterior olfactory nucleus, piriform cortex 
and olfactory tubercle. High level of MCHR1 is found in 
the shell of the nucleus accumbens, an area involved in 
reward-related behaviour. Furthermore, MCHR1 is highly 
expressed in the amygdala and hippocampus suggesting 
its role in the regulation of emotions (i.e. fear or anxiety) 
and  memory. In addition, it has an influence on general 
mood and arousal levels [2, 5, 7]. 
MCHR2 receptors are 340 amino acids long, located 
on the long arm of chromosome 6 (6q16.2-6q21). The 
homology between MCHR1 and MCHR2 is only 38 %. Sur-
prisingly, rats do not have MCHR2 receptor, whereas it is 
found in guinea pigs, rabbits, in ferrets, dogs, monkeys 
and humans. MCHR2 activation increases the intracellular 
Ca2+ level and it couples to Gq-proteins [2].
In the ob/ob mouse model, the PMCH expression 
increases two-to three-fold with fasting. Leptin treatment 
blunts the fasting-induced increase of PMCH mRNA in 
both the wild type and ob/ob mice. The intracerebroven-
tricular administration of 5 µg MCH to rats led to rapid 
increase of chow consumption. Compared with control 
group, MCH-treated animals eat two-three-fold more over 
a six-hour period. Feeding can also be induced by injec-
tion of MCH directly into the paraventricular nucleus. 
Repetitive intramuscular injection of MCH into rats over a 
one-week period did not lead to obesity, whereas chronic 
infusion into the lateral ventricle led to both hyperphagia 
and weight gain [2, 8, 9]. These studies experimentally 
confirmed that MCH is essential to fasting response, but Figure 4: Structure of melanin-concentrating hormone receptor 1 (MCHR1). 
Figure 5: Signalling pathways of melanin-concentrating hormone receptor 1 (MCHR1) (left panel) and MCHR2 (right panel). MCH binding to 
receptors leading to G protein coupling (Gs, Gi, Gq). While, Gi activation causing decreased amount of cAMP (red arrows), Gq resulting in 
increased mitogen-activated protein kinase (MAPK) activity (blue arrows) via Ras and elevation of intracellular calcium level (mediated by 
inositol trisphosphate (IP3) and phospholipase C (PLC) activation). This cascade induces changes in cell proliferation and gene transcrip-
tion. [Protein kinase A=PKA; protein kinase C=PKC; diacylglycerol=DAG; MAPK kinase=MEK] (Adapted from Presse et al. [24])
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unbalanced expression contributes to positive energy 
balance leading to health problems.
Furthermore, the cytokine receptor interleukin-6 alfa 
(IL-6Rα) is co-expressed with MCH and orexin in human 
and mouse hypothalamus in the hypothalamic, periforni-
cal, dorsal and posterior areas, dorsomedial nucleus and 
in the zona incerta. In addition, MCH and orexin positive 
neurons contain IL-6Rα, suggesting that immune mecha-
nisms may also be involved in the orchestration of energy 
balance. [10].
The ventromedial nucleus of hypothalamus (VMH) is 
a satiety centre and a main target of leptin which inhibits 
feeding, increases energy expenditure and finally causes 
weight loss [11]. 
The lateral hypothalamic area (LHA) is the feeding 
centre. It has an important role in mediating hyperphagia 
which is induced by hypoglycaemia [12]. 
The Dorsomedial hypothalamic nucleus (DMH) has 
connection to VMH and the LHA and it integrates the 
information from these nuclei [13]. 
The ventromedial aspect of the arcuate nucleus, 
which produces the orexigenic peptides neuropeptide Y 
(NPY) and agouti-related peptide (AGRP), contains glu-
tamic acid decarboxylase (GAD) and vesicular gamma-am-
inobutyric acid (GABA) transporter (VGAT). Surprisingly, 
in the LHA orexin-producing neurons express vesicular 
glutamate transporter 1 (VGLUT1) or VGLUT2, but not 
GAD, whereas some MCH cells contain GAD [14–16]. The 
hypothalamus is the primary CNS region to control energy 
balance, but is also associated with thirst, reproduction, 
temperature, hormonal balance and biological rhythms. 
Lesions of lateral hypothalamus produce aphagia, adipsia 
and weight loss. As a compensatory mechanism MCH 
expression increases during fasting and encourages food 
intake [2, 15–18].
Experimentally MCH administration leads to rapid 
and robust feeding response, while chronic infusions 
results in mild obesity. MCH expression changes in states 
of altered energy balance, such as fasting and obesity. 
Silencing either PMCH or MCHR genes leads to a lean phe-
notype [2]. As we discussed MCH antagonists inhibit both 
feeding and diet-induced obesity [3–5].
In mammals, the widespread projections of MCH 
neurons in the lateral and basal hypothalamus suggest 
the complex role of peptide in the regulation of feeding 
behaviour, fluid intake, stress response, reproduction, 
arousal and sensory-motor integration [19]. 
3  The MCH system in avians
In avians, the diencephalon is highly developed and 
implicated in numerous physiological processes. A phy-
logenetic novelty is the very accurate thermoregulation 
centre located in bird’s hypothalamus, which is important 
to maintain the continuously high body temperature of 
avians. The diencephalon is divided into three parts like in 
the other vertebrates i.e. the thalamus, hypothalamus and 
epithalamus. The hypothalamus is a part of the reticular 
formation. It contains different secretory neurons which 
have roles in the neuroendocrine regulation [20].
Cardot et al. detected MCH immunopositivity in five 
species’ brain: Leghorn cocks, Guinea hens, quails, gos-
lings and ducks [21]. Neuronal perikarya were strongly 
positive in hypothalamus mainly in the periventricular 
hypothalamic nucleus in all species except the cocks, 
where only few perikarya showed immunoreactivity. 
Fibres and nerve terminals were very thin and sparse, 
especially in ducks and quails. In LHA immunopositivity 
were found in the periventricular nucleus, the ventricular 
nucleus and the dorsomedial nucleus. A lot of fibers had 
positive immunoreaction in the medial area of the thala-
mus. Although most of them were thin, some were long 
and unramified. 
Regarding the brainstem, innervation by MCH pos-
itive neurons was observed in all species in the rostral 
part of the pons and metencephalon, along the fourth 
ventricle, in the locus coeruleus, the locus subcoeruleus, 
the oral pontine reticular nucleus and the linear caudal 
nucleus. In the medulla oblongata some immunopositive 
fibers were detected in the medial vestibular nucleus, 
in the raphe nucleus, the posterior area of the caudal 
pontine reticular nucleus and the vestibular nuclei. In 
birds the MCH system, especially in the lateral and basal 
hypothalamus, has an important role in the limbic system 
and it coordinates the vegetative and endocrine functions 
as well as the emotional behaviour [21]. The non-mam-
malian vertebrates studies have identified several mam-
malian MCHR1/MCHR2-like receptors. According to the 
predictions seven mammalian MCHR-like receptor exist 
(MCHR1-MCHR7) in different species such as zebrafish 
or coelacanths [22]. However, our knowledge on MCHRs 
in avians is limited due to the absence of experimen-
tal studies. In a recent paper Cui et al. have identified a 
MCHR1-like receptor (chicken-MCHR4) and a pseudo 
MCHR2 in chickens [23]. The cMCHR4 is activated by 
chicken MCH (cMCH) and induces different signalling 
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pathways. They found that cMCHR4 is not orthologous to 
human MCHR1. As in human, the discovered receptor is 
also coupled to G-proteins. Regarding anatomical locali-
sation the cMCH expresses predominantly in the hypo-
thalamus, while cMCHR4 expresses widely in the brain. 
These findings suggest that MCH is highly conserved 
within vertebrates. Distribution of cMCHR4 can explain 
the complex regulatory role of MCH system in birds. In 
addition, fasting increases cMCH mRNA level in chicken 
hypothalamus indicating its essential function in con-
trolling avian energy balance [23].
4  Conclusion
MCH is highly conservative neuropeptide in mammals 
and avians, which plays a crucial role in the regulation 
of food intake and affectivity. A development of selective 
MCH system modulators could become promising thera-
peutic options in the treatment of obesity and obesity-re-
lated diseases (i.e. diabetes) or depression. Furthermore, 
in agriculture the enhancement of endogenous MCH 
levels in livestock may contribute to higher and more eco-
nomical meat yield. However, detailed morphological and 
physiological analysis of MCH system in different species 
is essential to examine the potential effects of novel phar-
macological agents on energy homeostasis.
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